Anne Marit de Groot - JoVE Visualize

Showing results (1-10 of 13) with videos related to

Pageof 2

Sort By:

Bioconjugate Chemistry|January 23, 2015

Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeationMie Kristensen, Anne Marit de Groot, Jens Berthelsen, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2017

Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacteriumAnne Marit de Groot, Guangsheng Du, Juha Mönkäre, et al.

Frontiers in Immunology|January 30, 2018

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus ToxoidAnne Marit de Groot, Anouk C M Platteel, Nico Kuijt, et al.

Nanoscale|November 11, 2015

Surface coating of siRNA-peptidomimetic nano-self-assemblies with anionic lipid bilayers: enhanced gene silencing and reduced adverse effects in vitroXianghui Zeng, Anne Marit de Groot, Alice J A M Sijts, et al.

Human Vaccines & Immunotherapeutics|August 14, 2025

Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancyGloria Aguilar, Gabriela Tapia-Calle, Cynthia Robinson, et al.

Molecular Therapy. Nucleic Acids|June 3, 2018

Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle DesignAnne Marit de Groot, Kaushik Thanki, Monique Gangloff, et al.

Medrxiv : the Preprint Server for Health Sciences|July 16, 2021

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19Dan H Barouch, Kathryn E Stephenson, Jerald Sadoff, et al.

Vaccine|June 6, 2022

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trialsJerald Sadoff, Mathieu Le Gars, Boerries Brandenburg, et al.

Plos One|October 5, 2022

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled studyViki Bockstal, Georgi Shukarev, Chelsea McLean, et al.

Journal of Extracellular Vesicles|March 18, 2021

Human milk extracellular vesicles target nodes in interconnected signalling pathways that enhance oral epithelial barrier function and dampen immune responsesMarijke I Zonneveld, Martijn J C van Herwijnen, Marcela M Fernandez-Gutierrez, et al.

Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:

Pageof 2

Bioconjugate Chemistry|January 23, 2015

Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeationMie Kristensen, Anne Marit de Groot, Jens Berthelsen, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2017

Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacteriumAnne Marit de Groot, Guangsheng Du, Juha Mönkäre, et al.

Frontiers in Immunology|January 30, 2018

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus ToxoidAnne Marit de Groot, Anouk C M Platteel, Nico Kuijt, et al.

Nanoscale|November 11, 2015

Surface coating of siRNA-peptidomimetic nano-self-assemblies with anionic lipid bilayers: enhanced gene silencing and reduced adverse effects in vitroXianghui Zeng, Anne Marit de Groot, Alice J A M Sijts, et al.

Human Vaccines & Immunotherapeutics|August 14, 2025

Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancyGloria Aguilar, Gabriela Tapia-Calle, Cynthia Robinson, et al.

Molecular Therapy. Nucleic Acids|June 3, 2018

Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle DesignAnne Marit de Groot, Kaushik Thanki, Monique Gangloff, et al.

Medrxiv : the Preprint Server for Health Sciences|July 16, 2021

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19Dan H Barouch, Kathryn E Stephenson, Jerald Sadoff, et al.

Vaccine|June 6, 2022

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trialsJerald Sadoff, Mathieu Le Gars, Boerries Brandenburg, et al.

Plos One|October 5, 2022

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled studyViki Bockstal, Georgi Shukarev, Chelsea McLean, et al.

Journal of Extracellular Vesicles|March 18, 2021

Human milk extracellular vesicles target nodes in interconnected signalling pathways that enhance oral epithelial barrier function and dampen immune responsesMarijke I Zonneveld, Martijn J C van Herwijnen, Marcela M Fernandez-Gutierrez, et al.

Pageof 2